Artiva Biotherapeutics, Inc. Common Stock (ARTV)

9.97

(-9.69%)

Operating Income Summary of Artiva Biotherapeutics, Inc. Common Stock

  • Artiva Biotherapeutics, Inc. Common Stock's latest annual operating income in 2023 was -30.67 Million USD , up 48.74% from previous year.
  • Artiva Biotherapeutics, Inc. Common Stock's latest quarterly operating income in 2024 Q1 was -14.49 Million USD , down -21.07% from previous quarter.
  • Artiva Biotherapeutics, Inc. Common Stock reported an annual operating income of -59.82 Million USD in 2022, down -12.31% from previous year.
  • Artiva Biotherapeutics, Inc. Common Stock reported an annual operating income of -53.27 Million USD in 2021, down -191.57% from previous year.
  • Artiva Biotherapeutics, Inc. Common Stock reported a quarterly operating income of -14.49 Million USD for 2024 Q1, down -21.07% from previous quarter.
  • Artiva Biotherapeutics, Inc. Common Stock reported a quarterly operating income of -30.67 Million USD for 2023 FY, up 48.74% from previous quarter.

Annual Operating Income Chart of Artiva Biotherapeutics, Inc. Common Stock (2023 - 2020)

Historical Annual Operating Income of Artiva Biotherapeutics, Inc. Common Stock (2023 - 2020)

Year Operating Income Operating Income Growth
2023 -30.67 Million USD 48.74%
2022 -59.82 Million USD -12.31%
2021 -53.27 Million USD -191.57%
2020 -18.27 Million USD 0.0%

Peer Operating Income Comparison of Artiva Biotherapeutics, Inc. Common Stock

Name Operating Income Operating Income Difference